CCL2 and pulmonary hypertension: Recent studies show that in the pathological pulmonary hypertension, miR-124 also controls pulmonary vascular fibroblast proliferation, migration and inflammation [18] by inhibiting the expression of MCP-1 and polypyrimidine tract-bind protein 1(PTBP-1).